Roche
In Brief This Week: PerkinElmer, Roche, T2 Biosystems, Co-Diagnostics, More
News items for the week of March 13, 2023.
Top Five Articles on 360Dx Last Week: Outlook for COVID-Testing Firms; FDA LDT Regulation; and More
Last week, readers were most interested in a story exploring the outlook for firms that have focused almost solely on COVID-19 testing.
Roche Nabs FDA Approval for Ventana PD-L1 Test as CDx for Libtayo
The immunohistochemistry test is used to detect programmed death-ligand 1 protein in non-small cell lung carcinoma patients.
Top Five Articles on 360Dx Last Week: UnitedHealthcare and Expanded Carrier Screening; and More
Last week, readers were most interested in a story about stricter enforcement by UnitedHealthcare of a policy deeming expanded screening medically unnecessary.
Point32Health Expands Coverage of Foundation Medicine CDx Tests for Patients With Advanced Cancer
FoundationOne CDx and FoundationOne Liquid CDx comprehensive genomic profiling tests will be available to Point32Health patients with advanced solid tumors.